No Data
*Special Treat Puli (300630.SZ) has artificially inflated profits by 0.669 billion yuan for two consecutive years; the company's stocks may be delisted.
*ST Puli (300630.SZ) issued a notice, the company received a decision from the China Securities Regulatory Commission on March 21, 2025...
Another huge bombshell! *ST Puli's major financial fraud has led to a direct (Delisted).
Over the past two years, profits were inflated by nearly 0.7 billion.
GTJA: Continuous iteration of anti-tumor therapies, domestic new drugs welcome breakthroughs.
GTJA focuses on products with significant differentiation advantages and leading companies in innovative segments.
Hainan Poly Pharm. Co., Ltd's (SZSE:300630) Shares Bounce 30% But Its Business Still Trails The Industry
*ST Puli (300630.SZ): Has not signed any form of related agreement with USA GPO Premier, Inc.
*ST Puli (300630.SZ) clarifies that as of now, the company has not engaged with USA GPO Premie...
Hainan Poly Pharm (300630.SZ): Major violations have triggered mandatory (Delisted) status. From January 7, it will be subject to "Delisting Risk Warning."
Hainan Poly Pharm (300630.SZ) issued an announcement that the company is suspected of illegal information disclosure and has been investigated by the China Securities Regulatory Commission.
Investors Holding Back On Hainan Poly Pharm. Co., Ltd (SZSE:300630)
